on 23 Apr 2025
Last Applicant/ Owned by
Roivant Sciences GmbH
Viaduktstrasse 8CH-4051 Basel
CH
Serial Number
2089117 filed on 8th Jan 2021
Correspondent Address
GOWLING WLG (CANADA) LLP
SUITE 2600, 160 ELGIN STREETOTTAWA
ONTARIO
CA
K1P1C3
Trademark usage description
pharmaceutical preparations for human use for use in dermatology, namely, dermatitis, skin pigmentation diseases, and skin injuries, for the treatment Read More11
11
11
11
2089117
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 16th Nov 2022 | Agent Changed |
Submitted for opposition 22 on 13th Jul 2022 | Search Recorded |
Submitted for opposition 20 on 13th Jul 2022 | Examiner's First Report |
Submitted for opposition 223 on 13th Jul 2022 | Total Provisional Refusal |
Submitted for opposition 256 on 4th Jan 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 4th Mar 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 3rd Mar 2021 | Created |
Submitted for opposition 31 on 3rd Mar 2021 | Formalized |
Submitted for opposition 30 on 8th Jan 2021 | Filed |
Submitted for opposition 228 on 8th Jan 2021 | International Registration |
This website uses cookies
Manage cookies
You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Advertisement
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously
Analytics
Analytical cookies are used to understand how visitors interact with the website.
Functional
Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website.